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Dopamine (DA) signals in the striatum are critical for a variety of vital processes, including 56 
motivation, motor learning and reinforcement learning. Striatal DA signals can be evoked by 57 
direct activation of inputs from midbrain DA neurons (DANs) as well as cortical and thalamic 58 
inputs to the striatum. In this study, we show that in vivo optogenetic stimulation of prelimbic 59 
(PrL) and infralimbic (IL) cortical afferents to the striatum triggers an increase in extracellular 60 
DA concentration, which coincides with elevation of striatal acetylcholine (ACh) levels. This 61 
increase is blocked by a nicotinic ACh receptor (nAChR) antagonist. Using single or dual 62 
optogenetic stimulation in brain slices from male and female mice, we compared the properties 63 
of these PrL/IL evoked DA signals with those evoked by stimulation from midbrain DAN axonal 64 
projections. PrL/IL evoked DA signals are undistinguishable from DAN evoked DA signals in 65 
their amplitudes and electrochemical properties. However, PrL/IL evoked DA signals are 66 
spatially restricted and preferentially recorded in the dorsomedial striatum. PrL/IL evoked DA 67 
signals also differ in their pharmacological properties, requiring activation of glutamate and 68 
nicotinic ACh receptors. Thus, both in vivo and in vitro results indicate that cortical evoked DA 69 
signals rely on recruitment of cholinergic interneurons (CINs), which renders DA signals less 70 
able to summate during trains of stimulation and more sensitive to both cholinergic drugs and 71 
temperature. In conclusion, cortical and midbrain inputs to the striatum evoke DA signals with 72 
unique spatial and pharmacological properties that likely shape their functional roles and 73 
behavioral relevance. 74 
(248 / 250 words) 75 
 76 




Significance Statement (120 words maximum) 78 
Dopamine signals in the striatum play a critical role in basal ganglia function such as 79 
reinforcement and motor learning. Different afferents to the striatum can trigger dopamine 80 
signals, but their release properties are not well understood. Further, these input-specific 81 
dopamine signals have only been studied in separate animals. Here we show that optogenetic 82 
stimulation of cortical glutamatergic afferents to the striatum triggers dopamine signals both in 83 
vivo and in vitro. These afferents engage cholinergic interneurons, which drive dopamine release 84 
from dopamine neuron axons by activation of nicotinic acetylcholine receptors. We also show 85 
that cortically evoked dopamine signals have other unique properties, including spatial restriction 86 
and sensitivity to temperature changes than dopamine signals evoked by stimulation of midbrain 87 
dopamine neuron axons. 88 
(120/120 words) 89 
 90 
 91 




Introduction (650 words maximum, including citations) 93 
The striatum receives dense innervation from midbrain DANs, which are the main source 94 
of DA in the striatum. DA plays a critical neuromodulatory role in regulating striatal circuitry 95 
and function (Surmeier et al., 2007; Gerfen and Surmeier, 2011; Burke et al., 2017). Disruptions 96 
in striatal DA levels are associated with many neurological and psychiatric disorders, such as 97 
Parkinson’s disease and substance abuse disorder (Gerfen, 2000; Luscher et al., 2020). DA is 98 
released from a fraction of the varicosities distributed along DAN axons, which contain 99 
specialized active zone-like sites (Sulzer et al., 2016; Liu et al., 2018; Liu and Kaeser, 2019). 100 
The axonal arborizations of DANs ramify extensively within the striatum and a single dopamine 101 
axon can spread over a significant area (around 3% in average) of the striatum (Matsuda et al., 102 
2009). DA released from axonal varicosities generates a rapid increase in local extracellular DA 103 
concentration. This extracellular increase leads to the activation of multiple types of DA 104 
receptors which are localized in dendrites, somas, and presynaptic terminals. Ultimately, this 105 
impacts the network activity of the striatum and drives behavior output (Tritsch and Sabatini, 106 
2012; Chuhma et al., 2014; Mamaligas et al., 2016; Burke et al., 2017; Shin et al., 2017; Lahiri 107 
and Bevan, 2020). This striatal DA signal is known to be triggered by two mechanisms. One 108 
mechanism involves action potential firing initiated at midbrain DAN somas, which propagates 109 
through dense axonal arborizations to reach active zone-like release sites in the striatum 110 
(Matsuda et al., 2009; Liu et al., 2018). In the other mechanism, DAN axons in the striatum are 111 
locally activated, independent of the action potential firing at DAN somas. This mode of DA 112 
release requires the activation of nAChRs expressed on DAN axons and synchronized activation 113 
of CINs, which is thought to give rise to local release of ACh (Cachope et al., 2012; Threlfell et 114 




This local intrastriatal trigger of DA release has only recently been demonstrated and is 116 
gaining attention as it represents a newly discovered means for striatal DA 117 
modulation/transmission. However, little is known about the differential/unique biophysical and 118 
pharmacological properties of locally evoked versus DAN-evoked DA transmission. Recent in 119 
vitro studies utilizing optogenetic stimulation and fast-scan cyclic voltammetry (FSCV) show 120 
that local DA signals can be triggered in the striatum by stimulation of glutamatergic inputs from 121 
thalamus (Threlfell et al., 2012; Kosillo et al., 2016; Johnson et al., 2017; Cover et al., 2019), 122 
motor cortex (Kosillo et al., 2016), or prefrontal cortex (PFC) (Mateo et al., 2017). These 123 
findings agree with previous literature showing in vivo DA signals in the striatum evoked by 124 
stimulation of PFC (Taber and Fibiger, 1993; Quiroz et al., 2016; Hill et al., 2018), hippocampus 125 
(Tritschler et al., 2018), or amygdala (Floresco et al., 1998). Furthermore, in vivo intrastriatal 126 
administration of glutamate and ACh was also shown to cause increases in extracellular DA 127 
concentration in the rat striatum (Giorguieff et al., 1976; Giorguieff et al., 1977; Leviel et al., 128 
1990; Shimizu et al., 1990). Altogether, this evidence supports an intrastriatal mechanism for DA 129 
signal generation that can be initiated by excitatory inputs to the striatum that require glutamate 130 
and ACh. While cortically evoked DA signals in the striatum have been reported, identifying the 131 
unique pharmacological and basic properties of these input-specific signals will allow us to 132 
selectively manipulate and target them, leading to a better understanding of their functional 133 
significance. In this study, we tackle this gap in knowledge using both in vivo microdialysis and 134 
in vitro FSCV with optogenetic stimulation. Particulally, we set up a novel approach using dual 135 
optogenetic stimulation in the same brain slices to input-specific evoke DA release and compare 136 
the properties of these DA signals in the striatum. 137 




Materials and Methods 141 
Animals. All animals used in the study were maintained in accordance with the guidelines of the 142 
National Institutes of Health Animal Care and the animal research procedures were approved by 143 
the NIAAA Animal Care and Use Committee for mice and by the NIDA IRP Animal Care and 144 
Use Committee for rats. Except for the in vivo microdialysis experiments, all experiments were 145 
carried out using male and female mice of C57BL/6 background. Heterozygote 146 
B6.SJL-Slc6a3tm1.1(cre)Bkmn/J mice (Backman et al., 2006)(The Jackson Laboratory, 006660) 147 
referred to as DATIRES-Cre+ mice and negative DATIRES-Cre− littermates considered as wild-type 148 
mice were used. To fluorescently label CINs, homozygote B6N.129S6(B6)-Chattm2(cre)Lowl/J mice 149 
(Rossi et al., 2011) (The Jackson Laboratory, 018957) were crossed with homozygote 150 
B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J mice (Madisen et al., 2010) (The Jackson Laboratory, 151 
007914), and the progeny is referred to as CIN-tdTomato mice. For the microdialysis 152 
experiments, male Sprague-Dawley albino rats (Charles River Laboratories, Wilmington, MA) 153 
were used. Rats were housed individually for the first week after intracranial injection, until 154 
suture removal, after which the rats were housed 2 per cage. All animals were housed on a 12 h 155 
light/dark cycle (06:30 - 18:30 light) with food and water ad libitum. 156 
 157 
Surgery and stereotaxic injection of AAV-ChR2 vectors. Injections were carried out as 158 
described previously (Adrover et al., 2014). Briefly, mice (5-6 weeks old) were anesthetized by 159 
inhalation of isoflurane-oxygen mixture and were placed in a stereotaxic frame (David Kopf). 160 
Adeno-associated virus (AAV) vectors with Cre recombinase dependent expression of 161 
Channelrhodopsin2 (ChR2) protein, AAV5-EF1a-DIO-hChR2(H134R)-EYFP (4 x 1012 IU/ml), 162 




(VTA/SNc; AP: −3.30, ML: ±0.60, DV: −4.50) of DATIRES-Cre+ mice. The AAV vectors 164 
AAV5-CaMKII-hChR2(H134R)-EYFP (4 x 1012 IU/ml) or AAV5-Syn-ChrimsonR-tdTomato 165 
(1.7 x 1013 IU/ml), were injected in the PFC (PrL cortex, AP: +2.10, ML: ±0.35, DV: −2.30; IL 166 
cortex, AP: +1.90, ML: ±0.30, DV: −3.20) of negative littermates or DATIRES-Cre+ mice. All 167 
stereotaxic coordinates were from bregma (in mm) according to the mouse atlas by Franklin and 168 
Paxinos (2007). 300-500 nl for VTA/SNc and 100-200 nl for PFC were injected at a flow rate of 169 
100 nl/min. Recordings were made after a minimum of 4 weeks of incubation. For mice injected 170 
in both VTA/SNc (DIO-ChR2-EYFP) and PFC (ChrimsonR-tdTomato), recordings were 171 
performed after a minimum of 8 weeks of incubation. Viral vectors were purchased from Gene 172 
Therapy Center Vector Core at University of North Carolina and Penn Vector Core at University 173 
of Pennsylvania. 174 
 175 
Slice preparation. Mice were anesthetized and rapidly decapitated. Brains were quickly 176 
removed, mounted and sliced using a vibratome (VT-1200S Leica) in an ice-cold cutting solution 177 
containing (in mM) 225 sucrose, 13.9 NaCl, 26.2 NaHCO3, 1 NaH2PO4, 1.25 glucose, 2.5 KCl, 178 
0.1 CaCl2, 4.9 MgCl2, and 3 kynurenic acid. The sagittal slices (240 μm) were incubated for 20 179 
min at 33 °C in artificial cerebrospinal fluid (ACSF) containing (in mM) 124 NaCl, 1 NaH2PO4, 180 
2.5 KCl, 1.3 MgCl2, 2.5 CaCl2, 20 glucose, 26.2 NaHCO3, and 0.4 ascorbic acid, and kept in the 181 
dark at room temperature before use. Recording chamber was perfused at 2 ml/min with ACSF 182 
heated at 32°C using an in-line heater (Harvard Apparatus). 183 
 184 
Fast-scan cyclic voltammetry (FSCV) and amperometry. FSCV was performed in the dorsal 185 




diameter, ~150 μm of exposed fiber) inserted into a glass pipette. Before use, the CFEs were 187 
conditioned with 8 ms long triangular voltage ramp (-0.4 to +1.2 and back to -0.4 V versus 188 
Ag/AgCl reference at 400 V/s) delivered every 15 ms. CFEs showing current above 1.8 μA or 189 
below 1.0 μA in response to the voltage ramp around 0.6 V were discarded. During the 190 
recording, the CFEs were held at −0.4 V versus Ag/AgCl and the same triangular voltage ramp 191 
was delivered every 100 ms. DA transients were evoked by electrical or optical single pulse, or 5 192 
pulses at 20 Hz stimulations. Using the same CFE and location, DA signals were evoked by 193 
alternating electrical and optical stimulations in some experiments. These data were combined 194 
with results from other experiments where either electrical or optical stimulation was used to 195 
evoke DA signals. For electrical stimulation, a glass pipette filled with ACSF was placed near 196 
the tip of the carbon fiber and a rectangular pulse (0.2 ms, 100 μA) was applied every 2 min. For 197 
optogenetic stimulation, a fiber optic (200 μm diameter, 0.22 NA, ThorLabs) connected to a blue 198 
LED (470 nm, 1.8 mW of maximal output power measured at the tip of the fiber optics, 199 
ThorLabs) was placed over the carbon fiber and light pulses (0.6 ms) were delivered every 2 min. 200 
For input-output curves, the widths of light pulse were 0.1, 0.2, 0.5, 1, 2, and 5 ms. For dual 201 
optogenetic recordings, two fiber optics connected to a purple LED (420 nm, 3.0 mW, ThorLabs) 202 
and an orange LED (590 nm, 0.7 mW, ThorLabs) respectively, were placed over the carbon fiber. 203 
Light pulses (0.6 ms for 420 nm and 0.6-2 ms for 590 nm) were delivered in an alternating 204 
pattern every 2 min. Data were collected with a retrofit headstage (CB-7B/EC with 5 MΩ 205 
resistor) using a Multiclamp 700B amplifier (Molecular Devices) after low-pass filter at 3 kHz 206 
and digitized at 100 kHz using a DA board (NI USB-6229 BNC, National Instruments). Data 207 
acquisition and analysis were performed using a custom-written software, VIGOR, in Igor Pro 208 




the evoked DA transients were converted to DA concentration according to the post 210 
experimental calibration using 1-3 μM DA. Amperometric recordings were performed using the 211 
same carbon-fiber electrodes held at −0.4 V versus Ag/AgCl and a 30 s long step to +0.6 V was 212 
applied. Single pulse or 5 pulses at 20 Hz stimulation were delivered at 20 s after switching to 213 
+0.6 V. Since we did not find major differences between PrL and IL in evoking DA transients, 214 
we combined the data obtained from two groups to represent DA transients evoked by PFC 215 
inputs (PFC-oDA). 216 
 217 
Cell-attached recordings. Striatal CINs from CIN-TdTomato mice injected with ChR2-EYFP in 218 
the PFC were identified by fluorescence and confirmed by their characteristic spontaneous firing 219 
pattern. Cell-attached recordings were performed from CINs in the striatum using glass pipette 220 
electrodes with a resistance of ∼3–4 MΩ, filled with an internal solution containing (in mM) 120 221 
cesium methanesulfonate, 20 CsCl, 10 HEPES, 0.2 EGTA, 10 sodium phosphocreatine, 4 Na2-222 
ATP, and 0.4 Na-GTP (pH, 7.25; 290–310 mOsm), at a holding potential of 0 mV. To estimate 223 
the strength of connectivity to CINs, the lowest light intensity needed to reliably evoke action 224 
potentials in CINs was determined, ranging from 0.4 mW for ‘high’ connectivity to 2.1 mW for 225 
‘low’ connectivity. The data were collected using a Multiclamp 700B amplifier after low-pass 226 
filter at 1 kHz and digitized at 5 kHz, using pClamp10 software (Molecular Devices). Spike 227 
fidelity was calculated as percentages of the number of AP evoked from 5 trials for both single 228 
pulse and trains stimulation. 229 
 230 
In vivo microdialysis and optogenetic stimulation of the cortical inputs. Rats (80-90 g) 231 




IU/ml; Gene Therapy Center Vector Core at University of North Carolina) in the PrL and IL 233 
cortex (AP: +3.0 mm, ML: 0.5 mm, DV: −3.5 and −5 mm with respect to bregma). Two injection 234 
sites per hemisphere were used and 300 nl of viral vector solution was delivered per site via a 235 
105 μm thick silica tubing injector coupled directly to a 1 μl syringe driven by an infusion pump 236 
(rate = 50 nl/min) during 10 min. The injector was left in place for an additional 10 min 237 
following each injection to allow for diffusion of the suspension. Ten weeks after viral vector 238 
injection, rats (350-400 g) underwent surgery for probe implantation according to previously 239 
published procedures (Quiroz et al., 2016). Briefly, a modified microdialysis probe with an 240 
embedded light-guiding optic fiber was implanted into the nucleus accumbens (NAc) shell (AP: 241 
+1.2 mm, ML: 0.5 mm, DV: -8.0 mm with respect to bregma). The probe was fixed to the skull 242 
with a stainless-steel screw and glass-ionomer dental cement. All surgical procedures were 243 
performed under anesthesia with 3 ml/kg of Equithesin (4.44 g of chloralhydrate, 0.972 g of Na 244 
pentobarbital, 2.124 g of MgSO4, 44.4 ml of propylene glycol, 12 ml of ethanol and distilled 245 
H2O up to 100 ml of final solution; NIDA Pharmacy, Baltimore, MD). To build the microdialysis 246 
probe with embedded optic fiber, the tip of an optic fiber (105 μm diameter core, 0.22 Numerical 247 
Aperture) was sculpted into a conical shape using a Flaming-Brown pipette puller fitted with a 248 
custom platinum heating filament (Sutter Instruments, Novato, CA) to allow for a larger area of 249 
stimulation. The conical optic fiber tip was embedded inside the microdialysis probe and 250 
implanted. Microdialysis experiments were performed in freely moving rats 24 h after probe 251 
implantation. Optical fiber was coupled to a 473 nm solid-state laser module and light 252 
stimulation was driven by a Grass S88 stimulator. Light stimulation was delivered for 20 mins as 253 
trains of light pulses (2 ms pulse duration; at 100 Hz for 160 ms; trains repeats once per second; 254 




1.2 MgCl2, was pumped through the optogenetic-microdialysis probe (rate = 1.25 μl/min). After 256 
a washout period of 90 min, dialysate samples were collected at 20 min intervals. After 80 min 257 
of baseline sampling, optogenetic stimulation was applied for 20 min and samples were collected 258 
for 80 additional minutes after the end of the stimulation. Samples were split and analyzed 259 
separately for glutamate, DA and ACh content. ACh and glutamate contents were measured by 260 
HPLC coupled to an ACh oxidase and glutamate oxidase enzyme reactors, respectively, and 261 
electrochemical detection (Eicom Corporation). DA was measured by HPLC coupled with a 262 
coulometric detector (5200a Coulochem III, ESA, Chelmsford, MA). At the end of the 263 
microdialysis experiment, animals were deeply anesthetized with Equithesin and perfused 264 
transcardially with 0.1 M phosphate buffered saline (PBS), followed by 4% formaldehyde in 0.1 265 
M PBS, pH 7.4. Brains were postfixed in the same fixative for 2 h and immersed in 20% 266 
sucrose/0.1 M PBS, pH 7.4, solution for 48 h at 4°C. Forty μm thick coronal sections were cut in 267 
a Leica (Nussloch, Germany) CM3050S cryostat at −20°C, collected in PBS, and stored in 268 
antifreeze-buffered solution (20% ethylene glycol, 10% glycerol, and 10% sucrose in PBS) at 269 
−80°C until processing. Sections were then evaluated for localization of implanted probes and 270 
ChR2-EYFP expression. Wide field images were acquired with a Typhoon laser scanner (GE 271 
Healthcare). Confocal fluorescence microscopy images were acquired with a Zeiss microscope 272 
(Examiner Z1, Zeiss, Gottingen, Germany) fitted with a confocal laser module (LSM-710, 273 
Zeiss). 274 
 275 
Drugs. Dihydro-β-erythroidine hydrobromide (DH E) was purchased from Tocris. Kynurenic 276 




(NBQX) and 3-((R)-2-Carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP) were purchased 278 
from Abcam. All other chemicals were purchased from Sigma. 279 
 280 
Statistical analysis. Statistical analysis was performed with Prism (GraphPad). One-sample t-281 
test, two-tailed paired t-test, repeated measures one-way (RM1W) ANOVA with or without 282 
mixed-effects models (MEM), or two-way (RM2W) ANOVA were used as specified. Tukey’s or 283 
Dunnett’s multiple comparisons test was used for post-hoc analysis as specified. The number of 284 
experiments, n, was expressed as the number of slices or cells/the number of mice or number of 285 






In vivo stimulation of PrL/IL inputs increases striatal ACh and DA concentration, and the 289 
increase in DA requires nAChR activation  290 
Published work in vivo shows that optogenetic stimulation of cortical inputs to the 291 
striatum can evoke DA release (Quiroz et al., 2016). However, this study provides no evidence 292 
that activation of these cortical inputs recruits striatal CINs or that the cortically evoked DA 293 
release in vivo require activation of striatal nAChRs. To assess these matters, we used in vivo 294 
microdialysis combined with optogenetic stimulation, as previously described (Quiroz et al., 295 
2016), and measured extracellular levels of ACh and DA in response to optogenetic stimulation 296 
of cortical inputs. A modified microdialysis probe with an embedded light-guiding optic fiber 297 
was implanted into the striatum of rats expressing ChR2-EYFP in the PrL/IL cortex (Figure 1A 298 
and B). On the experiment day, dialysate samples were collected at baseline for 80 min before 299 
stimulation started. Optogenetic stimulation of cortical axons within the striatum was delivered 300 
around the microdialysis probe as trains of light pulses (16 pulses at 100 Hz every 1 s for 20 301 
mins). Samples were collected for an additional 80 mins after stimulation and were split and 302 
analyzed separately for DA and ACh content or DA and glutamate. This long train of in vivo 303 
optogenetic stimulation of PrL/IL cortical axon fibers within the striatum produced an increase in 304 
extracellular concentration of DA in the striatal dialysate (185.1 ± 44.0% of baseline, n = 7; F = 305 
5.27, p = 0.0002, RM1W ANOVA; p = 0.0002 for 60 min vs. 80 min; Dunnett’s multiple 306 
comparisons test; Figure 1C), which coincided with an increase of extracellular ACh 307 
concentration (196.7 ± 36.6% of baseline, n = 7; F = 3.00, p = 0.0002, RM1W ANOVA; p = 308 




microdialysis findings support the hypothesis that cortical stimulation recruits CINs. In addition, 310 
when the in vivo optogenetic stimulation was performed in constant perfusion of the nAChR 311 
antagonist DHβE (10 μM) delivered locally via reverse dialysis, the same stimulation protocol 312 
did not cause any change in extracellular DA concentration in the striatal dialysates (96.5 ± 313 
11.6% of baseline, n = 9; F = 0.64, p = 0.70, RM1W ANOVA; Figure 1E), indicating that 314 
activation of nAChRs in the striatum is required for the cortically evoked DA release in vivo. As 315 
a control, we measured glutamate concentration in these same dialysates which showed 316 
increased glutamate levels and confirmed the delivery of cortical stimulation in the presence of 317 
the nAChR antagonist (184.3 ± 27.3% of baseline, n = 9; F6,45 = 4.01, p = 0.003, RM1W 318 
ANOVA with MEM; p = 0.0006 for 60 min vs. 80 min; Dunnett’s multiple comparisons test; 319 
Figure 1F). 320 
 321 
Stimulation of PrL/IL inputs to striatum is sufficient to evoke local DA signals in brain 322 
slices 323 
In order to precisely access the specific inputs and apply pharmacological agents, we 324 
used transgenic mice with combination of optogenetic stimulation. DA signals were recorded in 325 
the striatum using FSCV in mouse brain slice preparations. Release of DA from axonal 326 
projections within the striatum were evoked by electrical stimulation and compared with DA 327 
signals evoked by input-specific optogenetic stimulation. To achieve input-specific stimulation, 328 
ChR2-EYFP was expressed in either midbrain DANs and their axonal projections to the striatum 329 
using Cre-dependent viral vector injection in DATIRES-Cre+ mice (Figure 2A), or ChR2-EYFP in 330 
cortical neurons of the PrL/IL cortex and their projections to the striatum using viral injection in 331 




As expected, single brief pulses of electrical stimulation delivered via an electrode placed 333 
within the striatal tissue reliably evoked DA (electrically evoked DA transient, eDA) signals in 334 
striatal brain slices (Figure 2C). Also, direct optogenetic stimulation of midbrain DAN axonal 335 
projections within the striatum also evoked DA signals (referred here as DAN-oDA) upon 336 
delivery of a single brief pulse of blue light (0.6 ms), in agreement with previous published 337 
studies (Adrover et al., 2014; Melchior et al., 2015). Lastly, similar to the in vivo findings in 338 
Figure 1, selective optogenetic stimulation of axon projections from PrL/IL cortex into the 339 
striatum was also sufficient to trigger DA signals (referred as PFC-oDA) in the striatum of in 340 
slice preparation (Figure 2C). These PFC-oDA signals were also reliably evoked by brief single 341 
pulses of blue light (0.6 ms) in the ventral portion of the dorsomedial striatum in sagittal brain 342 
slices (Figure 2D). The viral expression around injection site was often large enough to include 343 
both PrL and IL regions of the cortex. For this reason, we combined data from the two regions. It 344 
is worth noting that these brain sections mainly contain the axon projections from PrL/IL 345 
neurons but not their cell bodies, which are localized to more medial sagittal sections of the brain 346 
(Figure 2B, inset). 347 
The current-voltage plots of DA signals evoked via the three different types of 348 
stimulation (electrical, optogenetic stimulation of DANs and optogenetic stimulation of PrL/IL) 349 
were indistinguishable and displayed current peaks at the expected oxidation (0.56 ± 0.01 V for 350 
eDA, n = 15 / 8; 0.58 ± 0.01 V for DAN-oDA, n = 14 / 6; 0.56 ± 0.01 V for PFC-oDA, n = 22 / 351 
13; F = 0.49, p = 0.62, RM1W ANOVA with MEM; Figure 2E) and reduction voltages (−0.17 ± 352 
0.01 V for eDA, −0.14 ± 0.01 V for DAN-oDA, −0.16 ± 0.02 V for PFC-oDA; F = 0.76, p = 353 
0.49, RM1W ANOVA with MEM; Figure 2E) for DA. The peak amplitude of eDA was 354 




DAN-oDA; 325 ± 23 nM for PFC-oDA; F2,12 = 13.430.76, p > 0.05, RM1W ANOVA with 356 
MEM; p = 0.01 for eDA vs. DAN-oDA, p = 0.0005 for eDA vs. PFC-oDA, and p = 0.99 for 357 
DAN-oDA vs. PFC-oDA; Tukey’s multiple comparisons test; Figure 2F), and the decay time 358 
constants (tau) were similarly longer with eDA (0.25 ± 0.01 s for eDA, 0.22 ± 0.01 s for DAN-359 
oDA, 0.23 ± 0.01 s for PFC-oDA; F2,12 = 13.43, p = 0.0009, RM1W ANOVA with MEM; p = 360 
0.004 for eDA vs. DAN-oDA, p = 0.009 for eDA vs. PFC-oDA, and p = 0.83 for DAN-oDA vs. 361 
PFC-oDA; Tukey’s multiple comparisons test; Figure 2G). Thus, we were able to reliable evoke 362 
steady DA signals by selective optogenetic stimulation of axon projections from PrL/IL cortex in 363 
the ventral portion of the dorsomedial striatum. The DA signals recorded using FSCV showed 364 
indistinguishable chemical and temporal characteristics, even when evoked by different inputs. 365 
 366 
Unique physical and pharmacological properties across input-specific DA signals 367 
We first explored the threshold for triggering the input-specific optogenetically evoked 368 
DA signals. The threshold was determined by constructing input-output curves and varying the 369 
light pulse durations from 0.1 to 5 ms in brain slices from mice expressing ChR2 in midbrain 370 
DANs or the PrL/IL region (Figure 3A and B). The relative amplitudes of DA transients were 371 
overlapping for pulses of 0.5-5 ms duration and both DAN-oDA and PFC-oDA signals showed 372 
maximal amplitude with 1-5 ms light pulse durations. However, very short light pulses (0.1 ms) 373 
evoked measurable DA signals only in slices in which ChR2 was expressed in midbrain DAN 374 
projections to the striatum, indicating a lower threshold for evoking DA signals with direct 375 
stimulation of DA neuron axons than with stimulation of cortical inputs (duration × input, F5,90 = 376 
11.58, p < 0.0001, RM2W ANOVA; post hoc for the duration of 0.1 ms: 33 ± 4% for DAN-377 




threshold for the cortically evoked DA signals could reflect technical differences like opsin 379 
expression levels, or other biological factors such as the density of innervation of cortical vs 380 
DAN axonal projections, difference in the release probability of the DA varicosities that respond 381 
to direct stimulation of DAN axons from those responding to cortical inputs, and/or the indirect 382 
and polysynaptic nature of the cortical-evoked DA signals. 383 
To determine whether PrL/IL activation elicits striatal DA release engage the CINs 384 
dependent mechanism as shown in in vivo microdialysis experiment (Figure 1), we then studied 385 
the basic pharmacological characteristic of DA signal evoked by stimulation of PFC inputs and 386 
compared them with those evoked by electrical and DAN inputs stimulation. In striatal brain 387 
slices, PFC-oDA signals were completely abolished by a mixture of AMPA and NMDA 388 
receptors antagonists (NBQX/CPP), while eDA and DAN-oDA signals were unaffected 389 
(amplitude after the antagonists = 0.3 ± 1.6% of baseline for PFC-oDA, n = 6 / 5; 107.3 ± 3.0% 390 
for eDA, n = 6 / 4; 99.8 ± 1.4% for DAN-oDA, n = 6 / 4; F2,3 = 694.8, p < 0.0001, RM1W 391 
ANOVA with MEM; p = 0.14 for eDA vs. DAN-oDA, p’s < 0.0001 for PFC-oDA vs. eDA or 392 
PFC-oDA vs. DAN-oDA; Tukey’s multiple comparisons test; Figure 3C and D). These findings 393 
indicate a requirement for ionotropic glutamate transmission for PrL/IL inputs to evoke local DA 394 
signals, which is in agreement with previous reports on the requirement of glutamate 395 
transmission for DA signals evoked by motor cortex and thalamic inputs to the striatum 396 
(Threlfell et al., 2012; Kosillo et al., 2016; Cover et al., 2019). Further, similar to our in vivo data 397 
(Figure 1D), DHβE also abolished PFC-oDA signals, and significantly depressed eDA signals, 398 
while having no effect on DAN-oDA signals (1.9 ± 1.4% of baseline for PFC-oDA, n = 11 / 7; 399 
21 ± 3% for eDA, n = 10 / 5; 99 ± 3% for DAN-oDA, n = 5 / 2; F2,7 = 395.2, p < 0.0001, RM1W 400 




p < 0.0001 for DAN-oDA vs. PFC-oDA; Tukey’s multiple comparisons test; Figure 3E and F). 402 
Taken together, the pharmacology results support the hypothesis that PFC-oDA signals are 403 
mediated by activation of glutamate synapses from PrL/IL cortex to striatal CINs, which excites 404 
them to fire and trigger ACh release, thereby driving DA release via activation of nAChRs on 405 
DAN axon fibers within the striatum. 406 
ACh is rapidly cleared by enzymatic degradation by acetylcholinesterase (Quinn, 1987). 407 
The extremely dense presence of acetylcholinesterase in the striatum (Zhou et al., 2001) assures 408 
the termination of cholinergic action. We also have previously shown the influence of the 409 
acetylcholinesterase on the DA transmission in the striatum (Shin et al., 2015; Shin et al., 2017). 410 
As acetylcholinesterase activity shows temperature dependence (Vidal et al., 1987), we then 411 
tested the temperature dependence of the input-specific DA transients by varying the temperature 412 
of the bath solution. The amplitude of both DAN-oDA and PFC-oDA signals increased linearly 413 
as the temperature was lowered from the standard 32°C to 25°C and both showed a tight 414 
negative regression with similar slopes significantly different from zero (−10.8 ± 0.6% per °C, n 415 
= 8 / 3, for DAN-oDA, and −10.8 ± 2.0% per °C, n = 6 / 3, for PFC-oDA; p’s < 0.0001; Figure 416 
3G and H). The temperature dependence of the DA signal amplitude likely reflects the change in 417 
rate of DA transporter activity with temperature. DA transporter activity was reported to have a 418 
temperature coefficient Q10 ranging from 1.39 to 2.95 (Zhu and Hexum, 1992), from which we 419 
estimate a Q10 of around 2.3 for the DA transporter for 24 - 37°C range. Our estimate predicts 420 
that large changes in the rate of DA reuptake by the transporter would be around the tested and 421 
physiological temperatures. Indeed, the decay of the DA transients, which is a parameter that 422 
reflects the clearance of extracellular DA by the transporter, was also affected as the temperature 423 




the decrease of the temperature (DAN-oDA: −0.017 ± 0.001 s/°C; PFC-oDA: −0.025 ± 0.001 425 
s/°C; Figure 3I), which corresponded with the linear increase in amplitude. However, raising the 426 
temperature from 33°C to 35°C caused a dramatic and selective drop in the amplitude of the 427 
PFC-oDA signals, compared to DAN-oDA signals (Figure 3G and H). The slope for PFC-oDA 428 
signals increased 3-fold from −11% to −31% per °C. 429 
Vidal et al. (1987) have reported on a high dependence with temperature of the activity of 430 
acetylcholinesterase from rat brain, which reaches maximal rate around 35°C. Our in vivo and in 431 
vitro pharmacology experiments showed that PFC-oDA signals require activation of nAChR. 432 
Therefore, we speculate that the observed steep temperature dependence of the signals is in large 433 
part mediated by rate increase in acetylcholinesterase activity. Furthermore, at physiological 434 
temperatures the PFC-evoked DA signals may be very localized near ACh release sites, 435 
presumably overlapping with nAChR expression in DAN axons. 436 
 437 
Activity dependent summation of the midbrain and cortical DA signals  438 
Trains of stimulation pulses has been shown to produce sublinear summation in the 439 
amplitude of DA signals evoked by electrical and optogenetic stimulation of DAN axon 440 
projections in the striatum in vitro (Zhang and Sulzer, 2004; Threlfell et al., 2010; Melchior et 441 
al., 2015; Shin et al., 2017). We then tested the degree of summation of the DA signals in 442 
response to short trains of stimulation pulses (5 pulses at 20 Hz) and compared it with the 443 
transients evoked by a single pulse (Figure 4A and B). This pattern of train stimulation was 444 
chosen based on burst firing patterns recorded in vivo for DANs during behavior (Schultz et al., 445 
1993; Hyland et al., 2002). Indeed, we found that trains of 5 pulses at 20 Hz evoke DA transients 446 




DAN-oDA (5p/1p: 1.44 ± 0.06, n = 5 / 3, for eDA; 1.92 ± 0.19, n = 5 / 2, for DAN-oDA; 1.00 ± 448 
0.02, n = 10 / 7; F2,2 = 110.6, p = 0.009, RM1W ANOVA with MEM; p = 0.04 for eDA vs. 449 
DAN-oDA, p = 0.03 for eDA vs. PFC-oDA, and p = 0.008 for DAN-oDA vs. PFC-oDA; 450 
Tukey’s multiple comparisons test; Figure 4A and B). On the contrary, PFC-oDA transients 451 
evoked by this train stimulation had similar amplitudes compared to those evoked by a single 452 
pulse, indicating no summation of DA signals evoked by PrL/IL inputs. In order to measure DA 453 
signals with better temporal resolution, we performed amperometric recordings and again 454 
compared DA signals evoked by single pulse and trains (Figure 4C). In line with the FSCV 455 
results, amperometric recordings showed that DAN-oDA signals display sublinear summation 456 
whereas PFC-oDA signals are indistinguishable between single pulse or trains of 5 pulses at 20 457 
Hz. The lack of summation in the PFC-oDA signals in response to trains resembles the findings 458 
obtained with DA signals evoked by synchronized activation of CINs (Threlfell et al., 2012; Shin 459 
et al., 2017) and further supports the idea that the PFC evoked local DA signals are mediated by 460 
synchronized action of CINs in response to stimulation of PrL/IL inputs. Note that the large 461 
transient current deflection in response to each pulse of stimulation (n = 5 / 4; Figure 4C, right) is 462 
suggestive of the action potential firing evoked in CINs and other striatal neurons by the 463 
optogenetic stimulation of PrL/IL inputs. The fact that every pulse of the train stimulation 464 
triggers a current deflection reflects the ability of PrL/IL inputs to evoke action potentials firing 465 
in downstream neurons and supports the idea that the lack of summation in DA signals is not 466 
likely due to the failure of action potential firing by CINs. To directly test the contribution of 467 
failure of action potential firing by CINs to the lack of summation in PFC-oDA signals, we 468 
carried out cell-attached recordings from CINs and measured action potential fidelity in response 469 




= 0.21; trains of 5: 81.5 ± 7.7%, n = 10 / 4, t = 2.42, p = 0.04; both with one sample t-test to 471 
100% value; Figure 4D and E). Although there was a small but significant percentage of failure, 472 
the totality of the data indicate that the lack of summation is not likely caused by action potential 473 
failure, but instead can be attributed to other downstream mechanisms such as desensitization of 474 
nAChRs (Threlfell et al., 2012; Shin et al., 2017). 475 
 476 
Input-specific DA signals are evoked by dual optogenetic stimulation in the same brain 477 
slice  478 
Thus far, DA signals evoked by the different inputs were recorded in brain slices from 479 
different mice that expressed ChR2 in either midbrain DANs or in PrL/IL cortex. In order to 480 
strictly test the segregation/distinction of these two pathways, it was important to examine these 481 
two inputs and compare the input-specific DA signals in the slice preparation from the same 482 
mice. We took advantage of opsins activated by different light wavelengths, specifically, ChR2 483 
and the red-shifted opsin ChrimsonR (Klapoetke et al., 2014). We first set up the conditions for 484 
selective stimulation of each opsin without cross-activation. In brain slices expressing only ChR2 485 
in midbrain DANs, pulses of purple light (420 nm) evoked reliable DA signal while similar and 486 
longer pulses of orange light (590 nm) did not trigger any detectable signals (Figure 5A). 487 
Conversely, in slices expressing only ChrimsonR in the PrL/IL cortex, brief orange light pulses 488 
evoked DA signal, but not purple light (Figure 5B). Thus, under these experimental conditions, 489 
ChR2 and ChrimsonR can be used in combination to selectively stimulate two different inputs by 490 
delivering pulses of two different light wavelengths without any detectable cross- activation. 491 
Next, in the same DATIRES-Cre+ mice, ChR2-YFP was expressed in midbrain DANs with a 492 




Figure 5C shows examples of the fluorescent expression pattern of ChR2-YFP (green) and 494 
ChrimsonR (red) in the same sagittal brain slice from this double-injected mouse. Figure 5D 495 
shows the experimental arrangement for the dual input recordings with the placement of the 496 
carbon fiber and the two fiber-optics for delivering the purple and orange light pulses that were 497 
used to activate ChR2 and ChrimsonR, respectively. In these slices with dual opsin expression, 498 
brief pulses of either purple or orange light evoked DA signals with indistinguishable current-499 
voltage plots showing the characteristic peaks for DA oxidation and reduction (Figure 5E). The 500 
DA concentration transients had comparable peak amplitudes with means of 407 ± 32 nM for 501 
DAN-oDA and 420 ± 36 nM for PFC-oDA (n = 43 / 13, t = 0.47, df = 42, p = 0.64, paired t-test; 502 
Figure 5F) and overlapping time courses as measured at 10 Hz sample rate of FSCV, in 503 
agreement with the results shown in Figure 2. The decay time constant of the DA transients were 504 
similar (0.28 ± 0.01 s for DAN-oDA and 0.28 ± 0.01 s for PFC-oDA, n = 43 / 13, t = 0.41, df = 505 
41, p = 0.68 from paired t-test; Figure 5F). 506 
Then, we tested the pharmacological properties of DAN-oDA and PFC-oDA by 507 
delivering alternating purple and orange light pulses and recording from a single carbon fiber. 508 
Application of the glutamate receptor antagonists NBQX/CPP (99.2 ± 3.1% of the baseline for 509 
DAN-oDA and 1.6 ± 1.1% for PFC-oDA, n = 5 / 3; t = 25.3, df = 4, p < 0.0001, two-tailed paired 510 
t-test; Figure 5G) or the nAChR antagonist DHβE (101.9 ± 0.6% of the baseline for DAN-oDA 511 
and 0.8 ± 0.8% for PFC-oDA, n = 5 / 3; t = 79.13, df = 4, p < 0.0001, two-tailed paired t-test; 512 
Figure 5H) completely abolished PFC-oDA signals while leaving DAN-oDA signals in the same 513 
location intact. These results confirm the findings from Figure 3, which use antagonists and 514 
single input optogenetic stimulation to evoke either DAN-oDA or PFC-oDA in separate 515 




with no apparent crossover in the optogenetic stimulation of ChR2 and ChrimsonR with the 517 
described wavelengths. More importantly, these pharmacological findings highlight the different 518 
mechanisms and the unique nature of the input-specific DA signals evoked by PFC and midbrain 519 
inputs. 520 
 521 
Cortically evoked signals are spatially restricted 522 
As shown in Figure 2D, DA signals evoked by selective stimulation of PrL/IL inputs 523 
were preferentially detected between the nucleus accumbens core and dorsal striatum. We then 524 
set out to investigate in more detail the spatial distribution of the input-specific DA signals using 525 
the dual-opsin expression approach by sampling the amplitude of DA signals across 18 different 526 
striatal areas of the sagittal brain slice while evoking responses with purple and orange light. 527 
While DAN-oDA signals were detected throughout the whole striatum, PFC-oDA signals were 528 
spatially restricted (Figure 6A and B). Both DAN-oDA and PFC-oDA signals showed significant 529 
correlations with the fluorescent intensity of the projections (p = 0.03 and r2 = 0.28 for DAN-530 
oDA; p = 0.01, r2 = 0.37 for PFC-oDA; Figure 6B). However, the slope of the linear regression 531 
was larger for DAN-oDA signals than PFC-oDA signals (10 vs 6 nM/AU, respectively; Figure 532 
6B). Thus, the intensity of the DAN labeled fibers was a good predictor of the magnitude of 533 
DAN-oDA signals. On the other hand, the presence of cortical axon fluorescence was not always 534 
a predictor of PFC-oDA signals, likely due to the larger density of passing cortical axons that are 535 
not synaptic terminal run through the striatum. 536 
Averaging the area responses in 5 brain slices from 3 mice, we found that the mean 537 
amplitude of the PFC-oDA signals was largest in the ventral part of the dorsal striatum, which 538 




projections from PrL/IL cortex (Figure 6C and D). However, the correlation between 540 
fluorescence intensity and amplitude of PFC-oDA signals is not always strong and, for example, 541 
the more intensely labeled caudal areas near the globus pallidus show almost no PFC-oDA signal 542 
(Figure 6C and D). The evidence of small or no PFC-oDA signals in the more caudal striatum 543 
could possibly reflect greater fiber density rather than innervation of the caudal portion of the 544 
striatum by the axonal projections from PrL/IL cortex. 545 
The number of CINs is less than 1% of the total striatal neurons and they are sparsely 546 
distributed throughout the striatum (Burke et al., 2017). We then quantified the density of CINs 547 
from the same area to further determine whether the distribution of CINs contribute to the spatial 548 
restriction of PFC-oDA signals. For this purpose, we took advantage of CIN-tdTomato mouse 549 
line which fluorescently labels CINs throughout the striatal slices (Figure 6E). The quantification 550 
analysis of cell numbers in 400 × 400 μm2 showed that the density of CINs was also highest in 551 
the middle part of the dorsomedial striatum (6 slices from 3 mice), suggesting that an uneven 552 
distribution of CINs could also contribute to the spatial restriction of the local DA signals evoked 553 
by PrL/IL cortical inputs to the ventral portion of the dorsomedial striatum. To further test 554 
whether the spatial profile of PFC-oDA signals is in part determined by the strength of the 555 
innervation of CINs by PrL/IL cortical neurons, we performed cell-attached recordings from the 556 
same CINs of CIN-TdTomato mice and measured the ability of PFC optogenetic stimulation to 557 
evoke action potentials in CINs throughout the striatum (46 CINs from 3 mice). We found that 558 
the connectivity followed a similar pattern to the PFC-oDA profile, and the probability that CINs 559 
will fire an action potential in response to PFC stimulation was higher in the central part of the 560 




In conclusion, this study offers a series of in vitro and in vivo evidence that stimulation of 562 
cortical inputs from the PrL/IL cortex can evoke DA release in the striatum via a local 563 
mechanism that recruits CINs and requires activation of nAChRs. Since these cortically evoked 564 
DA signals are spatially restricted and have different properties, we speculate that they are 565 
engaged in distinctive striatal functions from those assigned for DA signals evoked by midbrain 566 
DANs. 567 
 568 





This study provides strong evidence that DA signals in the striatum can occur both in 571 
vivo and in vitro in response to stimulation of PrL/IL cortical inputs. These PrL/IL evoked DA 572 
signals have distinctive pharmacological and physiological properties, compared to the DA 573 
signals evoked by DAN inputs. The in vitro experiments also introduce a dual optogenetic 574 
stimulation approach with which we can activate two different inputs to the striatum in the same 575 
brain slice, without apparent cross-activation. This study further reveals the spatial localization 576 
of the DA signals evoked by PFC inputs. 577 
We showed that the PrL/IL evoked DA signals require activation of glutamate and 578 
nicotinic ACh receptors, in line of a series of elegant published work. Using in vitro radioactive 579 
assays and in vivo microdialysis, it was first shown that locally administered ACh and glutamate 580 
can trigger DA release in the striatum (Giorguieff et al., 1976; Giorguieff et al., 1977). 581 
Giorguieff and coauthors (1976) showed that an nAChR antagonist blocked ACh-evoked DA 582 
signals, and speculated that “…the release of DA from dopaminergic terminals can be regulated 583 
by cholinergic presynaptic receptors exhibiting nicotinic characteristics.” To their credit, their 584 
conclusions agree with our interpretations of the findings from the current study as well as other 585 
recent optogenetic studies where it was shown that selective stimulation of CINs is sufficient to 586 
evoke DA signals (Cachope et al., 2012; Threlfell et al., 2012; Wang et al., 2014; Shin et al., 587 
2017). The involvement of CINs in the glutamate-dependent DA signals was also suggested by 588 
early work by Taber and Fibiger (1994) who showed that electrical stimulation of PFC can 589 
increase levels of ACh in the striatum and further supported by more recent optogenetic studies 590 
(Threlfell et al., 2012; Kosillo et al., 2016; Johnson et al., 2017; Mateo et al., 2017; Cover et al., 591 




Here, our experiments confirmed the requirement for ionotropic glutamate receptor 593 
activation in the PFC-evoked DA signals as previously shown (Mateo et al., 2017). We also 594 
show that nAChRs are required for the PrL/IL evoked DA signals in vitro, similar to other 595 
findings when stimulating inputs from other cortical (Kosillo et al., 2016) and thalamic areas 596 
(Threlfell et al., 2012; Kosillo et al., 2016; Cover et al., 2019) and indirectly in vivo (Mateo et al., 597 
2017). Our results from the in vivo microdialysis experiments reproduce the original findings 598 
from Quiroz et al. (2016) showing that optogenetic stimulation of PFC inputs increases striatal 599 
levels of DA in vivo (and glutamate, as expected, Figure 1). More importantly, we showed that 600 
stimulation of PrL/IL inputs to the striatum also elevates striatal levels of ACh in vivo and that 601 
this cortically evoked DA signals are blocked when a nAChR antagonist is perfused (Figure 1C 602 
and D). Thus, these findings support that idea PrL/IL inputs form excitatory synapses on striatal 603 
CINs and can activate then to evoke ACh release (Figure 1C). In agreement with this conclusion, 604 
recent work showed that optogenetic stimulation of either M1 motor cortex or parafascicular 605 
nucleus of the thalamus can induce release of ACh that was detected using exogenous G-protein 606 
coupled inward rectifying K-current expressed in medium spiny neurons (Mamaligas et al., 607 
2019). Taken together, our findings from both in vitro and in vivo strongly support the 608 
hypothesis of a local mechanism for evoking DA release in the striatum, in addition to the more 609 
conventional mechanism based on midbrain DAN firing. This local mechanism engages striatal 610 
CINs, the targets of inputs from PFC, which have an essential role in evoking DA release from 611 
DAN fibers. 612 
DA signals evoked by PrL/IL inputs and those evoked by DAN fibers stimulation share 613 
common properties such as overlapping electrochemical profiles of the voltammetric currents 614 




Figure 5E and F). However, there are also several differences between the input-specific DA 616 
signals. First, DANs evoked DA signals do not require activation of either ionotropic glutamate 617 
receptors or nAChRs (Figure 3C-F, Figure 5G and H), confirming the direct nature of this 618 
mechanism that is triggered by ChR2 evoked action potentials in DAN axon fibers. Second, 619 
PrL/IL evoked DA signals display different temperature sensitivity and a higher threshold 620 
compared to DAN-oDA requiring a longer duration of light stimulation as determined in the 621 
input-output relationship (Figure 3 and 4). This finding may reflect the poly-synaptic nature of 622 
the cortically evoked signals and the requirement of synchronized activation of CINs in order to 623 
trigger DA release by this local mechanism (Threlfell et al., 2012; Kosillo et al., 2016; Liu et al., 624 
2018). Third, the amplitude of DANs evoked DA signals increases as the number of stimulation 625 
pulses increases, indicating some summation in the DA signals evoked by a train of stimulation 626 
pulses (Figure 4A and B). In contrast, the amplitude of DA signals in response to a train of 627 
pulses of cortical input stimulation is similar to the amplitudes obtained in response to a single 628 
pulse of stimulation, indicating no summation under this condition for the local mechanism 629 
(Figure 4A and B). ChR2 displays use-dependent inactivation when stimulated at high frequency 630 
(Hass and Glickfeld, 2016). However, the lack of summation by the train stimulation is unlikely 631 
due to this use-dependent inactivation of ChR2 since 20 Hz train stimulation was still able to 632 
evoke action potentials in CINs recorded in cell attached mode (Figure 4D and E) and 633 
amperometry recording showed large deflections in response to train stimulation (Figure 4C). 634 
Anecdotally, these current deflections disappeared when the ionotropic glutamate receptor 635 
antagonists were applied, also supporting the idea that firing in CINs and other downstream 636 
neurons occurs in response to 20 Hz train stimulation. The lack of summation was also reported 637 




et al., 2012; Shin et al., 2017), which was suggested to be due to nAChRs desensitization. We 639 
speculate then that the lack of summation we report here by 20 Hz trains in PrL/IL evoked DA 640 
signals, which also require nAChRs activation, is also due to desensitization. 641 
To directly study and compare the input-specific DA signals in the same animal, we 642 
established dual optogenetic stimulation using a red-shifted opsin, ChrimsonR, in combination 643 
with the blue-light activated ChR2. Two wavelengths for excitation were chosen based on the 644 
excitation spectrum of each opsin (Klapoetke et al., 2014), 590 nm for ChrimsonR and 420 nm 645 
for ChR2, which showed no cross-activation (Figure 5A and B). This dual optogenetic approach 646 
was further validated using pharmacology in animals expressing ChR2 in midbrain DANs and 647 
ChrimsonR in PrL/IL neurons. We found that PrL/IL evoked DA signals were completely 648 
blocked by antagonists of either ionotropic glutamate receptors or nAChRs, without affecting 649 
DAN-oDA signals in the same slice (Figure 5G and H). Therefore, we determined that the two 650 
inputs can be activated independently using this dual optogenetic approach in brain slices from 651 
the same animal. 652 
Interestingly, using this dual optogenetic approach, an intriguing spatial pattern was 653 
revealed for the cortically evoked PrL/IL DA signals. While DAN-oDA signals were recorded 654 
throughout the striatum, PrL/IL oDA signals were spatially restricted to a “hot-spot” region 655 
around the boundary between the nucleus accumbens core and dorsal medial striatum (Figure 6). 656 
This hot-spot area for the PrL/IL oDA signals corresponds to the same area where we found the 657 
highest density of CINs in our analysis. Thus, CIN density could contribute in part to the 658 
generation of this hot-spot area for the PrL/IL evoked DA signals. Further, we also found that 659 
this area has the highest intensity of fluorescently labeled PrL/IL fibers, as well as the highest 660 




cortical connectivity (Voorn et al., 2004). Our initial interest was to study the PFC projections to 662 
the accumbens. However, since PrL/IL evoked DA signals were largest and more reliable in the 663 
ventral DS (Figure 6), recordings were performed in this area. Altogether, these findings suggest 664 
that PrL/IL inputs and the synaptic innervation to CINs are preferentially localized to the 665 
dorsomedial subregion, giving rise to the largest cortically evoked DA signals.  666 
From the mechanism described here for this PrL/IL evoked DA signals, we propose that 667 
any input to the striatum that strongly activates CINs (cortical, thalamic, or any other brain 668 
region) can in theory evoke local DA signals in the striatum. We also speculate, based on ours 669 
and other groups’ works, that these glutamate-driven DA signals can similarly happen in other 670 
striatal subregions. The selective localization of PrL/IL evoked DA signals suggests the 671 
existence of a “topographic map” for the local DA signals where inputs from different cortical 672 
subregions can trigger local DA signals at the striatal subregion which they innervate. Spatial 673 
segregation of input-specific DA signals in the striatum is a new concept introduced here that is 674 
rarely considered in the field. This concept may become helpful in understanding how DA 675 
signals in the striatum can be involved in so many diverse processes ranging from reinforcement 676 
learning and motivation to motor output and action selection. 677 
(1499/1500 words) 678 




Figure legends 680 
 681 
Figure 1. Effect of the nAChR antagonist DHβE on the extracellular DA level evoked by 682 
local optogenetic stimulation of PFC fibers in vivo. 683 
A. A diagram showing the injection of ChR2-EYFP in the PrL and IL cortices (green circle) and 684 
projection to the striatum with the microdialysis-optogenetics probe in a sagittal brain view. B.  685 
Left, optogenetic-microdialysis probe schematics; a. liquid inlet, b. dialysis membrane, c. liquid 686 
outlet, d. sculpted optic fiber. Middle, probe tip detail. Scale bar: 0.2 mm. Right, a picture of the 687 
optogenetic-microdialysis probe showing light spread pattern at the probe tip. Scale bar: 1 mm. 688 
C-D. Time course of extracellular concentrations of (C) DA (red) and (D) ACh (black) in the 689 
NAc. E-F. Time course of extracellular concentrations of (E) DA (red) and (F) glutamate (Glu, 690 
green) in the NAc with constant perfusion (reverse dialysis) of the nAChR antagonist DHβE (10 691 
μM). Time 0-60 represents the values of samples before stimulation; the period of optogenetic 692 
stimulation (20 min) is represented as a train of blue vertical lines. Results are expressed as mean 693 
± SEM of percentage of the average of three values before stimulation. * p < 0.05, ** p < 0.01, 694 
*** p < 0.001. 695 
 696 
Figure 2. Striatal DA signals evoked by midbrain and cortical inputs. 697 
A. Example of the fluorescence pattern (bottom) observed in a sagittal brain slice from a 698 
DATIRES-Cre+ mice injected with DIO-ChR2-EYFP in the midbrain (top). B. Example of the 699 
fluorescence pattern (bottom) observed in a sagittal brain slice from a C57Bl6/J (DATIRES-Cre–) 700 
mice injected with ChR2-EYFP in the PrL or IL cortex (top). The inset shows a more medial 701 




color voltammograms when evoked by electrical stimulation (eDA, left), optogenetic stimulation 703 
of DAN fibers (DAN-oDA, middle), or optogenetic stimulation of PFC inputs (PFC-oDA, right). 704 
All three CV plots show the electrochemical profile of DA oxidation. Scalebars: 100 nM. D. A 705 
sagittal brain section modified from The Mouse Brain Atlas (Franklin and Paxinos, 2007) 706 
showing the FSCV recording sites from mice injected with ChR2-EYFP in the PrL (filled) and 707 
IL (empty) cortex. E. The oxidation (top) and reduction (bottom) voltages from the CV plots of 708 
eDA (left), DAN-oDA (middle), and PFC-oDA (right) were plotted as averages with SEMs. The 709 
open and filled circles represent individual values. F-G. (F) DA peak concentrations and (G) 710 
decay time constants of eDA (left), DAN-oDA (middle), and PFC-oDA (right) were plotted as 711 
averages with SEMs. The open circles represent individual values. For PFC-oDAs, the same 712 
color code was applied as in (D) for PrL and IL according to injection location.  Data points in E-713 
G include experiments where electrical and optogenetic stimulation were delivered alternatingly 714 
in the same slice or in different slices (see Materials and Methods). ** p < 0.01, *** p < 0.001. 715 
LV: lateral ventricle, DS: dorsal striatum, ac: anterior commissure, AcC: accumbens core, AcSh: 716 
accumbens shell, VP: ventral pallidum, PBP: parabrachial pigmented nucleus, SNR: sbstantia 717 
nigra reticulata, Th: thalamus, Tu: olfactory tubercle.  718 
 719 
Figure 3. DAN-oDA and PFC-oDA show different physical and pharmacological 720 
properties. 721 
A. Representative DAN-oDA (left) and PFC-oDA (right) transients evoked with different light 722 
pulse duration (in ms). Scalebars: 100 nM, 0.5 s. B. oDA amplitudes normalized to their 723 
maximum response were averaged and plotted as a function of the stimulus duration. C. 724 




application of the glutamate receptor antagonists, NBQX and CPP (both 5 μM). The dotted line 726 
(upper) represents the amplitude of DA transients before the drugs. Scalebars: 200 nM, 2 s. D. 727 
Averages with SEM of DA amplitude after NBQX and CPP were plotted. The open circles 728 
represent individual value. E. Representative traces of eDA, DAN-oDA, and PFC-oDA 729 
transients before and after bath application of the β2-contatining nAChR antagonist, DHβE (1 730 
μM). Scalebars: 200 nM, 2 s. F. Averages with SEM of DA amplitude after DHβE were plotted. 731 
The open circles represent individual value. *** vs. DAN-oDA, ### vs. eDA. G. Representative 732 
traces of DAN-oDA (left) and PFC-oDA (right) transients at 25, 32, and 35°C. The dotted line 733 
(upper) represents the oDA amplitude at 32°C. Scalebars: 200 nM, 2 s. H. Average oDA peak 734 
amplitudes normalized to 32°C and I. average oDA decay time constants were plotted as a 735 
function of temperature. * p < 0.05, *** and ### p < 0.001. 736 
 737 
Figure 4. PFC-oDA shows no summation by train stimulations. 738 
A. Representative DA traces of eDA, DAN-oDA, and PFC-oDA transients evoked by single 739 
pulse (1p, thin traces) or train of 5 pulses at 20 Hz (5p, thick traces). Scale bars: 200 nM, 2 s. B. 740 
Averages with SEM of the DA amplitude ratio (5p/1p) for eDA, DAN-oDA, and PFC-oDA 741 
transients were plotted. The open circles represent individual values. C. Representative 742 
amperometric traces for DAN-oDA (left) and PFC-oDA (right) transients evoked by single pulse 743 
(grey traces) or train of 5 pulses at 20 Hz (color traces). PFC-oDA amperometric transients 744 
evoked by 50 at 20 Hz were indistinguishable from 1p stimulation, except the large deflection at 745 
the stimulation time for 5p pulses. Scale bars: 200 pA, 100 ms. D. Representative cell-attached 746 




bars: 20 pA, 100 ms. E. Averages with SEM of the action potential fidelity were plotted for the 748 
single pulse and train stimulation. The open circles represent individual values. **** p < 0.0001. 749 
 750 
Figure 5. Dual opsin expression to evoke cortical and midbrain DA signals in the same 751 
brain slices. 752 
A, B. Left, Representative traces of DA signals evoked by either 420 nm or 590 nm light pulses 753 
from mice expressing (A) only ChR2 in midbrain DANs or (B) only ChrimsonR in PrL/IL 754 
cortex. Right, oDA amplitudes were plotted as pairs for each wavelength. C. Example of the 755 
fluorescence patterns with filter set for yellow signal (left) or red signal (right) from a sagittal 756 
brain slice of a DATIRES-Cre+ mice injected with ChrimsonR-TdTomato in the PFC and DIO-757 
ChR2-EYFP in the midbrain. D. Configuration to the FSCV DA recording using a carbon fiber 758 
and two fiber optics delivering 420 nm and 590 nm, respectively. E. Representative DA 759 
transients, CV plots and color voltammograms of DAN-oDA and PFC-oDA. F. Left, Amplitudes 760 
were plotted as pairs for DAN-oDA and PFC-oDA recorded from same slices. Right, Averages 761 
with SEM of decay time constant were plotted for DAN-oDA and PFC-oDA. The dots represent 762 
individual values. G. Left, Representative traces of DAN-oDA (top) and PFC-oDA (bottom) 763 
before and after the application of glutamate receptor antagonists NBQX and CPP. Right, 764 
Averages with SEM of DAN-oDA and PFC-oDA were plotted as a function of time as 765 
NBQX/CPP was applied. H. Left, Representative traces of DAN-oDA (top) and PFC-oDA 766 
(bottom) before and after the application of nAChR antagonists DHβE. Right, Averages with 767 
SEM of DAN-oDA and PFC-oDA were plotted as a function of time as DHβE was applied. 768 
 769 




A. The locations of carbon fiber and two fiber optics were adjusted to measure DAN-oDA (left) 771 
and PFC-oDA (right) from each location where the corresponding oDA’s were superimposed on 772 
the fluorescence patterns. Scale bars: 500 μm. B. Peak amplitudes of DAN-oDA (top) and PFC-773 
oDA (bottom) were plotted as a function of florescence intensity at each location shown in (A). 774 
The dotted lines represent linear regression between the oDA amplitudes and the fluorescence 775 
intensities. C. PFC-oDAs were measured from 74 locations (around between 1.0 and 1.2 mm in 776 
ML coordinate) of mice injected with ChR2-EYFP in PrL/IL cortex and color-coded according 777 
to their peak DA concentrations. The average PFC-oDA amplitudes were calculated and color-778 
coded for the three sub-regions. D. The PFC inputs fluorescence intensities were color-coded for 779 
the same 74 locations in (C). The averages from the three sub-regions were calculated and color-780 
coded. E. Left, Fluorescence image of striatal CINs labeled with td-Tomato. (Inset) Examples of 781 
identified CINs (red) from the area with the dotted yellow line. Right, the average numbers of 782 
CINs per 400 x 400 μm2 (area as shown in the inset) were calculated and shown for the three sub 783 
regions. F. Using cell-attached patch recording, action potentials evoked by PFC stimulation 784 
were observed from a total of 46 CINs. For each CIN, a minimum light intensity to evoke action 785 
potentials was determined to score the connectivity. The white circles with a thicker line 786 
represent CINs which did not show any evoked action potentials even with the maximum light 787 
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